{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:06:41Z","timestamp":1789009601095,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001516","name":"National Heart Foundation of New Zealand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001516","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008002","name":"Vancouver Coastal Health Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cjcopen.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CJC Open"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.cjco.2026.06.001","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T16:54:08Z","timestamp":1781542448000},"page":"1208-1218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and Echocardiographic Characteristics of Neuroendocrine Tumours and Carcinoid Heart Disease: Insights from a Contemporary Canadian Cohort"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0830-1521","authenticated-orcid":false,"given":"Joshua","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Mazengarb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina L.","family":"Luong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Y.C.","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa S.M.","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margot K.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Gin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Jue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvathy","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Loree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2674-6316","authenticated-orcid":false,"given":"Darwin F.","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjco.2026.06.001_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.15798","article-title":"Epidemiology of neuroendocrine neoplasms in the US","volume":"8","author":"Dasari","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cjco.2026.06.001_bib2","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1161\/01.CIR.77.2.264","article-title":"Carcinoid heart disease: relationship of circulating vasoactive substances to ultrasound-detectable cardiac abnormalities","volume":"77","author":"Lundin","year":"1988","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2026.06.001_bib3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1470-2045(17)30110-9","article-title":"The frequency of carcinoid syndrome at neuroendocrine tumor diagnosis: a large population-based study using SEER-Medicare data","volume":"18","author":"Halperin","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cjco.2026.06.001_bib4","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa021451","article-title":"Factors associated with progression of carcinoid heart disease","volume":"348","author":"M\u00f8ller","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjco.2026.06.001_bib5","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/01.CIR.87.4.1188","article-title":"Clinical and echocardiographic spectrum in 74 patients","volume":"87","author":"Pellikka","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2026.06.001_bib6","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1161\/CIRCULATIONAHA.105.553750","article-title":"Prognosis of carcinoid heart disease: analysis of 200 cases over two decades","volume":"112","author":"M\u00f8ller","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2026.06.001_bib7","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.amjcard.2006.07.092","article-title":"Carcinoid heart disease in patients without hepatic metastases","volume":"99","author":"Bernheim","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjco.2026.06.001_bib8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000443612","article-title":"Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors (PROMID): results of long-term survival","volume":"104","author":"Rinke","year":"2017","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.cjco.2026.06.001_bib9","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJMoa1316158","article-title":"Lanreotide in metastatic enteropancreatic neuroendocrine tumors","volume":"371","author":"Caplin","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjco.2026.06.001_bib10","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/MPA.0000000000000850","article-title":"The North American Neuroendocrine Tumor Society consensus guidelines for surveillance and medical management of midgut neuroendocrine tumors","volume":"46","author":"Strosberg","year":"2017","journal-title":"Pancreas"},{"key":"10.1016\/j.cjco.2026.06.001_bib11","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13146","article-title":"European Neuroendocrine Tumor Society (ENETS) 2022 guidance paper for carcinoid syndrome and carcinoid heart disease","volume":"34","author":"Grozinsky-Glasberg","year":"2022","journal-title":"J Neuroendocrinology"},{"key":"10.1016\/j.cjco.2026.06.001_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ctrv.2016.05.003","article-title":"Diagnosis and management of gastrointestinal neuroendocrine tumors: an evidence-based Canadian consensus","volume":"47","author":"Singh","year":"2016","journal-title":"Cancer Treatment Rev"},{"key":"10.1016\/j.cjco.2026.06.001_bib13","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s12471-017-1011-2","article-title":"Carcinoid heart disease: a guide for screening and timing of surgical intervention","volume":"25","author":"Hart","year":"2017","journal-title":"Neth Heart J"},{"key":"10.1016\/j.cjco.2026.06.001_bib14","first-page":"1342","article-title":"2017 comprehensive update of the Canadian Cardiovascular Society guidelines for the management of heart failure","volume":"33","author":"Ezekowitz","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjco.2026.06.001_bib15","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.amjsurg.2022.03.054","article-title":"The prevalence, operations, and outcomes of carcinoid heart disease","volume":"224","author":"Macfie","year":"2022","journal-title":"Am J Surg"},{"key":"10.1016\/j.cjco.2026.06.001_bib16","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020475","article-title":"Progression of carcinoid heart disease in the modern management era","volume":"10","author":"Baron","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cjco.2026.06.001_bib17","article-title":"Screening for carcinoid heart disease: trends and future perspectives","volume":"22","author":"Mouser","year":"2024","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"key":"10.1016\/j.cjco.2026.06.001_bib18","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1136\/hrt.2004.040329","article-title":"Carcinoid heart disease: presentation, diagnosis, and management","volume":"90","author":"Fox","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.cjco.2026.06.001_bib19","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.amjcard.2010.01.017","article-title":"Echocardiographic follow-up of treated patients with carcinoid syndrome","volume":"105","author":"Mansencal","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjco.2026.06.001_bib20","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jacc.2016.12.030","article-title":"Diagnosing and managing carcinoid heart disease in patients with neuroendocrine tumors: an expert statement","volume":"69","author":"Davar","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2026.06.001_bib21","article-title":"Contemporary management of severe carcinoid heart disease","volume":"30","author":"Geran","year":"2025","journal-title":"JACC Case Rep"},{"key":"10.1016\/j.cjco.2026.06.001_bib22","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.amjcard.2007.08.045","article-title":"Analysis of 150 patients with carcinoid syndrome seen in a single year at one institution in the first decade of the twenty-first century","volume":"101","author":"Bhattacharyya","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjco.2026.06.001_bib23","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1200\/JCO.2008.18.7047","article-title":"Chromogranin-A and N-terminal pro-brain natriuretic peptide: an excellent pair of biomarkers for diagnostics in patients with neuroendocrine tumor","volume":"27","author":"Korse","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cjco.2026.06.001_bib24","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.amjcard.2010.12.025","article-title":"Risk factors for the development and progression of carcinoid heart disease","volume":"107","author":"Bhattacharyya","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjco.2026.06.001_bib25","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1002\/cncr.11226","article-title":"Carcinoid heart disease: the role of urinary 5-hydroxyindoleacetic acid excretion and plasma levels of atrial natriuretic peptide, transforming growth factor-beta and fibroblast growth factor","volume":"97","author":"Zuetenhorst","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.cjco.2026.06.001_bib26","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0735-1097(98)00354-4","article-title":"Echocardiographic and biochemical evaluation of the development and progression of carcinoid heart disease","volume":"32","author":"Denney","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2026.06.001_bib27","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.echo.2025.05.013","article-title":"Echocardiographic evaluation of carcinoid heart disease","volume":"38","author":"Ayoub","year":"2025","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.cjco.2026.06.001_bib28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.echo.2025.01.006","article-title":"Guidelines for the echocardiographic assessment of the right heart in adults and special considerations in pulmonary hypertension: recommendations from the American Society of Echocardiography","volume":"38","author":"Mukherjee","year":"2025","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.cjco.2026.06.001_bib29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3390\/jcm8030405","article-title":"Carcinoid heart disease and decreased overall survival among patients with neuroendocrine tumors: a retrospective multicenter Latin American cohort study","volume":"8","author":"Uema","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.cjco.2026.06.001_bib30","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.122.014772","article-title":"Recovery of tricuspid valve function after resection of a primary ovarian carcinoid tumor","volume":"16","author":"Wong","year":"2023","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cjco.2026.06.001_bib31","first-page":"961","article-title":"Favorable outcome of a severe carcinoid cardiopathy after complete resection of the primary ovarian tumor","volume":"22","author":"Kalinsky","year":"1998","journal-title":"Gasteroenterol Clin Biol"},{"key":"10.1016\/j.cjco.2026.06.001_bib32","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.euje.2006.07.003","article-title":"Echocardiographic diagnosis of carcinoid disease: exceptional evolution after ovarian tumor resection without cardiac surgery","volume":"8","author":"Gonzalez","year":"2007","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.cjco.2026.06.001_bib33","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0025-6196(11)60834-3","article-title":"Role of hepatic resection for patients with carcinoid heart disease","volume":"83","author":"Bernheim","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cjco.2026.06.001_bib34","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1093\/ehjci\/jeac106","article-title":"2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"23","author":"Lyon","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.cjco.2026.06.001_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1353612","article-title":"A systematic review and meta-analysis of the diagnosis and surgical management of carcinoid heart disease","volume":"11","author":"Namkoong","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.cjco.2026.06.001_bib36","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3390\/jcdd11110359","article-title":"Cardiac surgery and transcatheter intervention for valvular heart disease in carcinoid syndrome: risk factors, outcomes, and evolving therapeutic strategies","volume":"11","author":"Piscione","year":"2024","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/j.cjco.2026.06.001_bib37","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/bjc.2014.468","article-title":"Serial surveillance of carcinoid heart disease: factors associated with echocardiographic progression and mortality","volume":"111","author":"Dobson","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cjco.2026.06.001_bib38","article-title":"One-stop transcatheter pulmonary and tricuspid valve replacement for carcinoid heart disease treatment","volume":"31","author":"Veas","year":"2025","journal-title":"JACC Case Rep"},{"key":"10.1016\/j.cjco.2026.06.001_bib39","article-title":"Simultaneous transcatheter pulmonary and tricuspid valve replacement in carcinoid heart disease","volume":"30","author":"Dannenberg","year":"2025","journal-title":"JACC Case Rep"},{"key":"10.1016\/j.cjco.2026.06.001_bib40","doi-asserted-by":"crossref","first-page":"341","DOI":"10.14503\/THIJ-15-5310","article-title":"Transcatheter pulmonary valve replacement in a carcinoid heart","volume":"43","author":"Loyalka","year":"2016","journal-title":"Tex Heart Inst J"}],"container-title":["CJC Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X26002234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X26002234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T02:20:33Z","timestamp":1789006833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589790X26002234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2589790X26002234"],"URL":"https:\/\/doi.org\/10.1016\/j.cjco.2026.06.001","relation":{},"ISSN":["2589-790X"],"issn-type":[{"value":"2589-790X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and Echocardiographic Characteristics of Neuroendocrine Tumours and Carcinoid Heart Disease: Insights from a Contemporary Canadian Cohort","name":"articletitle","label":"Article Title"},{"value":"CJC Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjco.2026.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the Canadian Cardiovascular Society.","name":"copyright","label":"Copyright"}]}}